This is a preview of subscription content, log in via an institution to check access.
Reference
Habbous S, et al. Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease. Value in Health : 18 Oct 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.08.3020
Rights and permissions
About this article
Cite this article
Ca-free phosphate binders a cost-effective choice in CKD?. PharmacoEcon Outcomes News 790, 6 (2017). https://doi.org/10.1007/s40274-017-4451-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4451-4